oblimersen sodium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for oblimersen sodium, covering 2018-08-31 to 2018-08-31. Get the full timeline:
Most recent: Clinical Trial Update: Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma [EARLY_Phase 1]